Science Current Events | Science News | Brightsurf.com
 

Recent Methylphenidate Current Events | Methylphenidate News

Page 1 of 2 | 27 Results
Previous0102   Next   
Sort By: Relevance | Page Views
ADHD medications do not cause genetic damage in children
In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to a new study by researchers at the National Institutes of Health (NIH) and Duke... view more (2008-11-20)

Caffeine experts at Johns Hopkins call for warning labels for energy drinks
Johns Hopkins scientists who have spent decades researching the effects of caffeine report that a slew of caffeinated energy drinks now on the market should carry prominent labels that note caffeine doses and warn of potential health risks for consumers.   view more (2008-09-24)

Post-marketing studies finding adverse events in drugs used in children
The Food and Drug Administration Modernization Act (FDAMA, 1997), designed to stimulate more drug safety studies in children, has resulted in more than 130 label changes since its inception nearly six years ago, according to researchers at Duke Children's Hospital.   view more (2008-09-02)

PET imaging focuses on medication's purported ability to improve mental performance
Concerned by the growing numbers of people using stimulant medications such as methylphenidate (MP)-either legally or illegally-to improve attention and focus, researchers used positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) to assess the effects of the drug... view more (2008-06-17)

New analysis shows DAYTRANA offered ADHD symptom control for 12 months
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRAN (methylphenidate transdermal system) between boys and girls aged 6 to 12 years with Attention... view more (2008-05-08)

Repeated methamphetamine use causes long-term adaptations in brains of mice, researchers find
Repeatedly stimulating the mouse brain with methamphetamine depresses important areas of the brain, and those changes can only be undone by re-introducing the drug, according to research at the University of Washington and other institutions.   view more (2008-04-10)

Journal SLEEP: Methylphenidate can have sleep benefits in adults with ADHD
Treatment with methylphenidate (MPH) appears to have beneficial effects on sleep parameters in adults with ADHD, including increased sleep efficiency and a feeling of improved restorative value of sleep, according to a study published in the March 1 issue of the journal SLEEP.   view more (2008-03-03)

Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin
Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin, including idiopathic hypersomnia,... view more (2007-12-03)

Mayo Clinic study indicates medication for ADHD may help student outcomes
In an 18-year-study on attention-deficit hyperactivity disorder (ADHD), Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD.   view more (2007-09-19)

MPH improves vigilance performance of ADHD children with poor sleep
In the first known study of its kind, an article published in the August 1st issue of the journal SLEEP finds that children with attention deficit hyperactivity disorder (ADHD), and whose sleep efficiency is poor, experience significant improvement on some measures of the Continuous Performance... view more (2007-08-01)

Pediatric Ritalin Use May Affect Developing Brain, New Study Suggests
Use of the attention deficit/hyperactivity disorder (ADHD) drug Ritalin by young children may cause long-term changes in the developing brain, suggests a new study of very young rats by a research team at Weill Cornell Medical College in New York City.   view more (2007-07-20)

Does Stimulant Treatment for ADHD Increase Risk of Drug Abuse?
Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse.   view more (2007-06-19)

Growth in ADHD medication use due to improved ADHD identification in adult and female patients
Attention deficit hyperactivity disorder (ADHD) has been traditionally viewed as a childhood disorder, while ADHD in adults has been underdiagnosed and undertreated.   view more (2007-06-08)

Columbia Study Examines ADHD's Role in Smoking
Are you easily forgetful, distracted, impulsive or fidgety? Do you find that smoking helps you alleviate these symptoms?   view more (2006-11-16)

DAYTRANA (methylphenidate transdermal system) provides individualized ADHD symptom management
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its Attention Deficit Hyperactivity Disorder (ADHD) patch, DAYTRANA tm (methylphenidate transdermal system), has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when the ADHD patch is taken off... view more (2006-10-30)

Popular ADHD drug safe and effective for pre-schoolers
A new study by researchers from the Johns Hopkins Children's Center and five other medical centers concludes that carefully measured, low doses of methylphenidate (Ritalin) are safe and effective for attention-deficit and hyperactivity disorder (ADHD) in preschoolers.   view more (2006-10-24)

Preschoolers with ADHD improve with low doses of medication
The first long-term, large-scale study designed to determine the safety and effectiveness of treating preschoolers who have attention deficit/hyperactivity disorder (ADHD) with methylphenidate (Ritalin) has found that overall, low doses of this medication are effective and safe.   view more (2006-10-17)

Researchers find not all drugs are equal in treating teen drivers with ADHD
Researchers at the University of Virginia Health System have found that teenage drivers with attention deficit hyper activity disorder (ADHD) drive better when they took OROS methylphenidate (OROS MPH), a controlled-release stimulant, rather than extended release amphetamine salts (se-AMPH ER).   view more (2006-09-06)

Washington University researchers find almost half of kids with ADHD are not being treated
In contrast to claims that children are being overmedicated for attention-deficit/hyperactivity disorder (ADHD), a team of researchers at Washington University School of Medicine in St. Louis has found that a high percentage of kids with ADHD are not receiving treatment.   view more (2006-08-07)

Ritalin packs punch by elevating norepinephrine, suppressing nerve signal transmissions
Methylphenidate (Ritalin) elevates norepinephrine levels in the brains of rats to help focus attention while suppressing nerve signal transmissions in the sensory pathways to make it easier to block out extraneous stimuli, a Philadelphia research team has found.   view more (2006-05-30)

Mixed amphetamine salts most effective in the treatment of ADHD in youths
Stimulant medications, such as mixed amphetamine salts (MAS) and methylphenidates are significantly more effective than nonstimulant ADHD medications or novel stimulants, such as modafinil, in the treatment of children with attention-deficit/hyperactivity disorder (ADHD).   view more (2006-05-25)

Delayed-release stimulant used to treat ADHD may be less subject to abuse
A team led by Massachusetts General Hospital (MGH) researchers has found that a delayed-release stimulant used to treat attention-deficit hyperactivity disorder (ADHD) may be less likely to be abused than other stimulant drugs.   view more (2006-03-01)

Positive study results for methylphenidate transdermal system
Shire announced at the US Psychiatric and Mental Health Congress in Las Vegas, Nevada, that its investigational methylphenidate transdermal system (MTS) demonstrated statistically significant reductions in the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD).   view more (2005-11-14)

Medication shows promise in the treatment of hyperactivity associated with autism-related disorders
Medication commonly used to treat attention-deficit hyperactivity disorder (ADHD) may be effective for treatment of hyperactivity symptoms in children with autism and related pervasive developmental disorders.   view more (2005-11-08)

Positive study results for methylphenidate transdermal system
Shire announced at a major medical meeting in Toronto, Canada, that its investigational methylphenidate transdermal system (MTS) demonstrated statistically significant reductions in the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) and was generally well tolerated in patients aged 6... view more (2005-10-24)
Page 1 of 2 | 27 Results
Previous0102   Next   
Sort By: Relevance | Page Views
© 2008 BrightSurf.com